Congress Speakers

  • Silviu Brill, Israel | Congress Chairperson

    Silviu Brill, Israel | Congress Chairperson

    Dr Silviu Brill is Specialist in Anesthesiology and Pain Management, Director of the Institute for Pain Medicine, Tel Aviv Medical Center, Israel. Past- President of the Israeli Pain Association and Past President, Pain Section of the Israeli Society of Anesthesiology.
  • Winfried Häuser, Germany | Congress Chairperson

    Winfried Häuser, Germany | Congress Chairperson

    Prof. Dr. med. Winfried Häuser is specialist of general internal medicine, psychosomatic medicine and pain medicine. He is senior consultant for gastroenterology, hepatology and pain/palliative care medicine, Department of Internal Medicine I, Klinikum Saarbrücken Germany.
  • Julie Dumouchel, Canada

    Julie Dumouchel, Canada

    Julie Dumouchel is the Director of Clinical Operations at Canopy Health Innovations (CHI) – the partly-owned R&D subsidiary of Canopy Growth. Although fairly new to cannabis/cannabinoid research, over the past 20+ years, Julie held various R&D roles in the pharmaceutical industry (Merck then Bayer), biotechnology (Methylgene), and CRO (Quintiles), with a primary focus in Oncology. 
  • Elon Eisenberg, Israel

    Elon Eisenberg, Israel

    Prof. Eisenberg has been the director of the Institute of Pain Medicine at Rambam Health Care Campus, Haifa, Israel, and the President of the Israeli Pain Association. He is currently the director of the Pain Research Unit at the Institute of Pain Medicine, Rambam Health Care Campus and a Professor of Neurology and Pain Medicine at the Faculty of Medicine in the Technion - Israel Institute of Technology.
  • Tjalling Erkelens, The Netherlands

    Tjalling Erkelens, The Netherlands

    Tjalling Erkelens is the founder of Bedrocan and currently holds the position of CEO / chairman of the board.  He started Bedrocan in the Netherlands as a family business, and he maintains these roots as Bedrocan continues to grow.  
  • Mary-Ann Fitzcharles, Canada

    Mary-Ann Fitzcharles, Canada

    Mary-Ann Fitzcharles has worked as a clinician, teacher and clinical researcher at McGill University, Montreal Canada since 1982. She completed her medical training at University of Cape Town, South Africa, and further specialized as a rheumatologist at the London Hospital, Whitechapel, England. 
  • Tamir Gedo, Israel

    Tamir Gedo, Israel

    Dr. Tamir Gedo serves as the CEO of BOL Pharma, one of Israel’s pioneers driving the worldwide medical cannabis industry. In this capacity, he draws upon a 25 year career as a marketing and business strategy expert serving in academic, government, and industry functions. 
  • Eva Hoch, Germany

    Eva Hoch, Germany

    Dr. Eva Hoch is a clinical psychologist and the head of the Cannabinoid Treatment and Research Group at the Department of Psychiatry, Ludwig-Maximilian University in Munich, Germany. She has an international reputation as senior researcher in the field of psychoactive substances with a special focus on cannabis. 
  • Hans G. Kress, Austria

    Hans G. Kress, Austria

    Hans Georg Kress earned his MD and PhD degrees in Germany. Certified by the Austrian and German Boards for Anaesthesiology and Intensive Care, he holds certificates in Critical Care Medicine, Emergency Medicine (Bavarian Medical Board), a Diploma in Special Pain Medicine of the Austrian Board of Physicians, and the European Diploma in Pain Medicine (EDPM).
  • Yuval Landschaft, Israel

    Yuval Landschaft, Israel

    Mgr. Landschaft holds the position as the Director Of the Israeli Medical Cannabis Agency – IMCA , since 2013.
  • David Meire, Israel

    David Meire, Israel

    David (Dedi) Meiri, PhD, is an Assistant Professor at the Faculty of Biology at the Technion Israel Institute of Technology and a member of the Technion Integrated Cancer Center (TICC). Dr. Meiri's scientific background is highly diverse. He holds a M.Sc. in biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. 
  • Andrew Moore, UK

    Andrew Moore, UK

    Andrew Moore was educated at Balliol College, Oxford, as a biochemist, and has worked in the NHS, in industry, and in academia. He was the founding editor of the EBM bulletin Bandolier. He has worked in pain research for over three decades. He is Chair of the IASP special interest group on systematic reviews and pain.
  • Holger Petri, Germany

    Holger Petri, Germany

    Holger Petri has been working as a pharmacist in a hospital pharmacy in Germany for more than 20 years. 
    During the first years of his professional career he became a specialist in the drug administration via enteral feeding tubes and has written a number of articles to make this issue more popular and known. 
  • Roman Rolke, Germany

    Roman Rolke, Germany

    Since 2014 Prof. Rolke is Chair and Director of the Department of Palliative Medicine, RWTH Aachen University. Before he was the Assistant Medical Director of the Department of Palliative Medicine (Director Prof. Lukas Radbruch) at the University Hospital of Bonn. He worked before as a neurologist (senior physician) in the Department of Neurology, University of Mainz, Germany. For some years, he also joined the pain research group of Prof. Rolf-Detlef Treede (Neurophysiology of pain, former IASP president).
  • Ethan Russo, USA

    Ethan Russo, USA

    Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI). 
  •  Piercarlo Sarzi-Puttini, Italy

    Piercarlo Sarzi-Puttini, Italy

    Piercarlo Sarzi-Puttini is currently Director Rheumatology Unit, L Sacco University Hospital, Milan, Italy. Professional Societes: Societa Italiana de Reumatologia, Collegio Medici Ospedalieri Italiana, American College of Rheumatology and Myopain Society. 
  • Nevenka Krcevski Skvar, Slovenia

    Nevenka Krcevski Skvar, Slovenia

    Assist. Prof. Nevenka Krcevski Skvarc, MD, MS, PhD, EDPM is specialist in Anesthesiology with additional knowledge in Pain Medicine and Palliative Care, Department of Anesthesiology, Intensive Care and Pain Treatment, University Medical Center Maribor, Slovenia.

  • M.J. (Marco) van de Velde, The Netherlands

    M.J. (Marco) van de Velde, The Netherlands

    In the period 1991-1995 Marco van de Velde he studied for his PhD about the modulatory role of fatty-acid metabolites in the signal transduction cascade in inflammatory processes. 
Install Google Tag Manager Copy the code below and paste it on to every page of your website. Paste this code as high in the of the page as possible: Additionally, paste this code immediately after the opening tag: For more information about installing the Google Tag Manager snippet, visit our Quick Start Guide .